Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
01/31/2007 | EP1747199A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
01/31/2007 | EP1747021A2 Self-immolative linkers and drug conjugates |
01/31/2007 | EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
01/31/2007 | CN1906178A 喹唑啉衍生物 Quinazoline derivatives |
01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
01/31/2007 | CN1906173A Protein modifier production inhibitor |
01/31/2007 | CN1906165A Novel herbicides |
01/31/2007 | CN1906163A 4-phenylpiperidine derivatives as renin inhibitors |
01/31/2007 | CN1906146A Process for producing epoxytriazole compound and intermediate therefor |
01/31/2007 | CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
01/31/2007 | CN1903853A Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity |
01/31/2007 | CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof |
01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
01/31/2007 | CN1297281C Method for treatment of leukaemia |
01/30/2007 | US7169942 Cannabinoid derivatives, methods of making, and use thereof |
01/30/2007 | US7169935 Process for preparing heterocyclic indene analogs |
01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
01/30/2007 | US7169930 Analogs of epothilone |
01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
01/30/2007 | US7169800 For cancer therapy |
01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
01/30/2007 | US7169791 Inhibitors of tyrosine kinases |
01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
01/30/2007 | US7169766 Administering nucleoside, or prodrug thereof; viricides |
01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
01/30/2007 | CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
01/30/2007 | CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
01/30/2007 | CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties |
01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
01/25/2007 | WO2007011623A1 Quinazoline derivatives useful in cancer treatment |
01/25/2007 | WO2007011618A1 Quinazoline derivatives useful in cancer treatment |
01/25/2007 | WO2007010946A1 Synovial cell proliferation inhibitor |
01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
01/25/2007 | WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases |
01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
01/25/2007 | WO2007009670A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
01/25/2007 | WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
01/25/2007 | WO2006131303A3 Peptide deformylase (pdf) inhibitors 4 |
01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
01/25/2007 | WO2006086358A3 Mitotic kinesin inhibitors |
01/25/2007 | WO2005090336A8 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands |
01/25/2007 | US20070021623 Novel process for preparation of nebivolol intermediates |
01/25/2007 | US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
01/25/2007 | US20070021509 Phosphate transport inhibitors |
01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
01/25/2007 | US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
01/25/2007 | US20070021456 Aminobenzimidazole derivatives |
01/25/2007 | US20070021440 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
01/25/2007 | US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
01/25/2007 | US20070021355 Antidepressants or foods and beverage for antidepression |
01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
01/25/2007 | DE102005034267A1 New 4-chromenonyl-1,4-dihydropyridine derivatives, useful for treatment of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor |
01/25/2007 | DE102005034266A1 New 8-dihydropyridyl-chromene derivatives, are antagonists of the mineralcorticoid receptor, useful for treatment and prevention of e.g. aldosteronism, hypertension and cardiac insufficiency |
01/25/2007 | DE102005034263A1 New 8-dihydropyridyl-chromene derivatives, useful for treatment and prevention of e.g. aldosteronism, hypertension and cardiac insufficiency, are antagonists of the mineralcorticoid receptor |
01/25/2007 | CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
01/25/2007 | CA2615380A1 Quinazoline derivatives useful in cancer treatment |
01/25/2007 | CA2615373A1 Quinazoline derivatives useful in cancer treatment |
01/25/2007 | CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
01/25/2007 | CA2615105A1 Histone deacetylase inhibitors |
01/25/2007 | CA2612469A1 Benzimidazole derivatives for treatment of inflammatory diseases |
01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
01/24/2007 | EP1745039A2 3-aryl-5,6-disubstituted pyridazines |
01/24/2007 | EP1745038A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
01/24/2007 | EP1745033A2 4,5-disubstituted-2-aryl pyrimidines |
01/24/2007 | EP1745024A1 1-aryl-4-substituted isoquinolines |
01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
01/24/2007 | EP1453492B1 Use of quinazolines to treat t-cell mediated diseases |
01/24/2007 | EP1408964B1 Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts |
01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
01/24/2007 | EP1363900B1 Isoindole-imide compounds, compositions and uses thereof |
01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
01/24/2007 | EP1072598B9 Pyrazolinone derivatives |
01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
01/24/2007 | CN1902194A Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
01/24/2007 | CN1902191A Amidopyrazole derivative |
01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
01/24/2007 | CN1902179A Methods and compositions for selectin inhibition |
01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
01/24/2007 | CN1901910A Substituted piperidines for the treatment of metabolic syndrome |